Abstract
Magnetic nanoparticles have attracted wide attention because of their usefulness as contrast agents for magnetic resonance imaging (MRI) or colloidal mediators for cancer magnetic hyperthermia. This paper examines these in vivo applications through an understanding of the problems involved and the current and future possibilities for resolving them. A special emphasis is made on magnetic nanoparticle requirements from a physical viewpoint, the factors affecting their biodistribution and the solutions envisaged for enhancing their half-life in the blood compartment and targeting tumour cells. Then, our synthesis strategies are presented and focused on covalent platforms based on maghemite and dextran and capable to be tailorderivatized by surface molecular chemistry. The opportunity of taking advantage of temperature-dependence of magnetic properties of some complex oxides for controlling the in vivo temperature is also discussed.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Andrä W 1998 Magnetism in medicine (eds) W Andrä and H Nowak (Weinheim: Wiley-VCH) p. 455
Bahadur D and Giri J 2003 Sadhana 28 639
Berry C C and Curtis A S G 2003 J. Phys. D. Appl. Phys. 36 R198
Bonnemain B 1998 J. Drug Targeting 6 167
Gneveckow U et al 2004 Med. Phys. 31 1444 (For more data: http://www.mag-force.de)
Grasset F, Mornet S, Demourgues A, Portier J, Bonnet J, Vekris A and Duguet E 2001 J. Magn. Magn. Mater. 234 409
Groman E V and Josephson L 1993 US Patent 5,248,492
Gupta A K and Gupta M 2005 Biomaterials 26 3995
Häfeli U 1998 Magnetism in medicine (eds) W Andrä and H Nowak (Weinheim: Wiley-VCH) p. 15
Hogemann D, Josephson L, Weissleder R and Basilion J P 2000 Bioconjugate Chem. 11 941
Johannsen M et al 2003 Int. J. Hyperthermia 21 637
Jordan A, Scholz R, Wust P, Schirra H, Schiestel T, Schmidt H and Felix R 1999 J. Magn. Magn. Mater. 194 185
Jung C W 1995 Magn. Reson. Imaging 13 675
Moghimi S M and Szebeni J 2003 Prog. Lipid Res. 42 463
Moghimi S M, Hunter A C and Murray J C 2001 Pharmacol. Rev. 53 283
Molday R S 1984 US Patent 4,452,773
Monfardini C and Veroneses F M 1998 Bioconj. Chem. 9 418
Mornet S, Vasseur S, Grasset F and Duguet E 2004a J. Mater. Chem. 14 2161
Mornet S, Duguet E and Portier J 2004b French Patent 2,855,315
Mornet S, Portier J and Duguet E 2005 J. Magn. Magn. Mater. 293 127
Moroz P, Jones S K and Gray B N 2002 Int. J. Hyperthermia 18 267
Okuhata Y 1999 Adv. Drug Delivery Rev. 37 121
Pankhurst Q A, Connolly J, Jones S K and Dobson J 2003 J. Phys. D. Appl. Phys. 36 R167
Sonvico F, Dubernet C, Colombo P and Couvrcur P 2005a Curr. Pharm. Des. 11 2091
Sonvico F et al 2005b Bioconj. Chem. 16 1181
Tartaj P, del Puerto Morales M, Veintemillas-Verdaguer S. González-Carreño T and Serna C J 2003 J Phys. D: Appl. Phys. 36 R182
Vasscur S et al 2006 J. Magn. Magn. Mater. 302 315 (doi:10.1016/j.jmmm.2005.09.026)
Wallis F and Gilbert F J 1999 J. R. Coll. Surg. Edinb. 44 117
Weinmann H J, Ebert W, Misselwitz B and Schmitt-Willich H 2003 Eur. J. Radiol. 46 33
Weissleder R, Elizondo G, Wittenberg J, Rabito C A, Bengele L and Josephson L 1990 Radiology 175 489
Zhang Y, Kohler N and Zhang M 2002 Biomaterials 23 1553
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Duguet, E., Vasseur, S., Mornet, S. et al. Towards a versatile platform based on magnetic nanoparticles for in vivo applications. Bull Mater Sci 29, 581–586 (2006). https://doi.org/10.1007/s12034-006-0007-0
Issue Date:
DOI: https://doi.org/10.1007/s12034-006-0007-0